The biggest M&A activity of the year arrived in the form of Merck KGaA’s earlier-disclosed agreement to buy Springworks Therapeutics Inc. for $47 per share in cash, which represents an equity value of ...

KfW Research’s latest study reveals that Germany is facing increased competition from China in EU export markets. While Germany still maintains ...